ADVERTISEMENT

Many people throughout the globe have been affected by breast cancer. The illness has claimed many lives, which is enough reason it should still be handled seriously.

Breast cancer is so common in the United States and is a major concern for many women. One in eight women will be diagnosed with severe breast cancer during their lifetime! That is around 12 percent of all American women in this category. The pharmaceutical industry’s top executives seem to be unfazed by this shocking fact. In reality, all they see is just money. On the other hand, scientists have discovered a cure for cancer that genuinely works!

Chemotherapy is not always the best when it comes to treating cancer. Your body gets destroyed from within by this drug after an injection. Even though it kills cancer cells, it also destroys healthy ones. There seems to be just a tiny number of people who can survive after taking the medicine. Cancer may be caused by chemotherapy; according to the National Institute for Occupational Safety and Health, cancer may be caused by chemotherapy soon. It advised that dealing with ordinary medications may be harmful, such as chemotherapy treatments.

Thanks to a new treatment, cancer tumors may now be eradicated within 11 days. It’s ridiculous, I know, but it’s true. The researchers looked at the impact of combining two medicines on breast cancer tumors. Herceptin and Lapatinib are the names of the medications shown to be quite successful.

Cancer cell proliferation and division are thought to be influenced by this protein. Also, unlike chemotherapy, it does not harm healthy cells. In addition, there are no known negative effects that cause hair loss.

A total of 257 women with positive HER2 breast cancer took part in the research. The medicine was given to half of these women, while the control group was left alone. The bodies of 11% of the women treated with this medicine had no signs of cancer cells after some time. Another 17 percent of patients had noticeably smaller tumors.

ADVERTISEMENT
Share this...
Leave a Reply

Your email address will not be published. Required fields are marked *